JAMA Ophthalmology · 2020 · 19 citations · 36 references
MedicineDermatologyEndocrinologyOcular ImagingOcular PharmacologyProstate DiseaseBenign Prostatic HyperplasiaMacular DiseaseMacular DisordersMacular ImagingOptical Coherence Tomography5 Alpha-reductase5-Alpha-reductase Inhibition5-Alpha-reductase Inhibitor TherapyMacular ExaminationMultimodal Ophthalmic ImagingOptical Coherence Tomography FindingsSex Hormone InfluencesSpectral-domain Optical Coherence Tomography
Importance: The neuroprotective action of sex hormones has been described. Data on the association between 5α-reductase inhibitor (5-ARI), a male sex hormone antagonist, and macular abnormalities are lacking to date. Objective: To assess the association between the use of 5-ARI for treatment of benign prostate hypertrophy and/or androgenic alopecia in men and macular abnormalities on optical coherence tomography imaging. Design, Setting, and Participants: This retrospective case-control, cross-sectional study included electronic health record data from 31 male patients who showed foveal cavitation on spectral-domain optical coherence tomography imaging from January 1, 2016, to June 30, 2019. Exposures: Receipt of 5-ARI for at least 2 years as treatment of benign prostate hypertrophy and/or androgenic alopecia. Main Outcomes and Measures: Clinical data and multimodal imaging findings and the proportion of 5-ARI users. Results: Among 31 male patients with foveal cavitation, 5-ARI was used for 10 of 14 patients (71.4%) with macular abnormalities of unknown origin and for 2 of 17 patients (11.8%) with macular abnormalities of well-known specific origin (P = .001). The mean age of these 14 patients was 74.7 years (range, 60.1-88.0 years). In the 15 eyes of 10 patients who had received 5-ARI for macular abnormalities of unknown origin, mean (SD) age was 72.8 (7.5) years, mean (SD) length of time receiving 5-ARI was 72.3 (39.2) months, and mean (SD) logMAR visual acuity was 0.08 (0.10) (Snellen equivalents, 20/24 [20/25]). Optical coherence tomography imaging showed a disease spectrum ranging from tiny foveal cavitation to an impending macular hole. Of the total male patients, 80.0% (8 of 10) had no symptoms. Conclusions and Relevance: The findings suggest that macular abnormalities associated with 5-ARI are characterized by cystoid abnormalities and foveal cavitation in male patients, which may progress to outer foveal defect and macular hole. These macular abnormalities associated with a male sex hormone antagonist suggested by this investigation warrant further corroboration.
36
World Medical Association Declaration of Helsinki
JAMA · 2013 · 29.4K citations
Richard V. Clark, David Hermann, Glenn R. Cunningham et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 460 citations
Perifoveal Müller Cell Depletion in a Case of Macular Telangiectasia Type 2
Michael B. Powner, Mark C. Gillies, Marina Tretiach et al. · Ophthalmology · 2010 · 258 citations · Full text
Medicine, Ophthalmology, Pathology +13
Sari Mäkelä, Hanna Savolainen, Einari Aavik et al. · Proceedings of the National Academy of Sciences · 1999 · 242 citations